Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the...

Keywords

MedicineCaptoprilMyocardial infarctionClinical endpointInternal medicineBlood pressureStroke (engine)Randomized controlled trialAngiotensin-converting enzymeClinical trialRelative riskACE inhibitorSurgeryCardiologyConfidence interval

Affiliated Institutions

Related Publications

Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2

Carlos M. Ferrario , Jewell A. Jessup , Mark C. Chappell +5 more

Background— Angiotensin-converting enzyme 2 (ACE2) has emerged as a novel regulator of cardiac function and arterial pressure by converting angiotensin II (Ang II) into the vaso...

2005 Circulation 1598 citations

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies

M R Law , Joan K. Morris , Nicholas Wald

With the exception of the extra protective effect of beta blockers given shortly after a myocardial infarction and the minor additional effect of calcium channel blockers in pre...

2009 BMJ 2727 citations

Captopril Treatment of Chronic Heart Failure in the Very Old

Veerle De Bock , Tony Mets , Marco Romagnoli +1 more

The study gives further evidence that angiotensin-converting enzyme inhibitor treatment for very old patients with chronic heart failure is useful.

1994 Journal of Gerontology 24 citations

Local Potentiation of Bradykinin-Induced Vasodilation by Converting-Enzyme Inhibition in Isolated Coronary Arteries

Wolfgang Auch–Schwelk , C. Bossaller , Matthias Claus +3 more

The interaction of angiotensin-converting enzyme (ACE) inhibitors and bradykinin was investigated in isolated bovine and human coronary arteries. Rings with and without endothel...

1992 Journal of Cardiovascular Pharmacology 33 citations

Decline in Cardiovascular Mortality

George A. Mensah , Gina S. Wei , Paul D. Sorlie +8 more

If the control of infectious diseases was the public health success story of the first half of the 20th century, then the decline in mortality from coronary heart disease and st...

2017 Circulation Research 785 citations

Publication Info

Year: 1999
Type: article
Volume: 353
Issue: 9153
Pages: 611-616
Citations: 2008
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

2008

OpenAlex

Cite This

APA Style

                            
                                
                                    Lennart Hansson, 
                                
                                    Lars Lindholm, 
                                
                                    Leo Niskanen
                                
                                et al.
                            
                            (1999). 
                            Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. 
                            The Lancet
                            , 353
                            (9153)
                            , 611-616.
                            https://doi.org/10.1016/s0140-6736(98)05012-0
                        

Identifiers

DOI: 10.1016/s0140-6736(98)05012-0